Physiological Considerations for Modeling in vivo Antibody-Target Interactions
Authors:
Open Access
- 24 February 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 856961
Abstract
The number of therapeutic antibodies in development pipelines is increasing rapidly. Despite superior success rates relative to small molecules, therapeutic antibodies still face many unique development challenges. There is often a translational gap from their high target affinity and specificity to the therapeutic effects. Tissue microenvironment and physiology critically influence antibody-target interactions contributing to apparent affinity alterations and dynamic target engagement. The full potential of therapeutic antibodies will be further realized by contextualizing antibody-target interactions under physiological conditions. Here we review how local physiology such as physical stress, biological fluid, and membrane characteristics could influence antibody-target association, dissociation, and apparent affinity. These physiological factors in the early development of therapeutic antibodies are valuable toward rational antibody engineering, preclinical candidate selection, and lead optimization.Keywords
Funding Information
- National Institutes of Health
This publication has 113 references indexed in Scilit:
- Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular ContextPLOS ONE, 2011
- A requirement for FcγR in antibody-mediated bacterial toxin neutralizationJournal of Experimental Medicine, 2010
- Diffusion in Brain Extracellular SpacePhysiological Reviews, 2008
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Factors determining antibody distribution in tumorsTrends in Pharmacological Sciences, 2008
- Macromolecular diffusion in the extracellular matrix measured by fluorescence correlation spectroscopyJournal of Biomedical Optics, 2008
- The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionCell Host & Microbe, 2007
- A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactionsProceedings of the National Academy of Sciences, 2006
- Mechanisms of cutaneous toxicities to EGFR inhibitorsNature Reviews Cancer, 2006
- Concepts in radiotherapy and immunotherapy: Anti-CD20 mechanisms of action and targetsSeminars in Oncology, 2005